Publications 2017

1. Mitjà O, Marks M, Bertran L, Kollie K, Argaw D, Fahal AH, Fitzpatrick C, Claire Fuller L, Izquierdo BG, Hay R, Ishii N,  JohnsonC,Lazarus JV, Meka A, Murdoch M, Ohene SA, Smal Pl, Andrew Steer A, Tabah EN, Tiendrebeogo A, Lance Waller L, Yotsu R, Walker SL, Kingsley Asiedut  K. Integrated Control and Management of Neglected Tropical Skin Diseases. PLoS Negl Trop Dis 2017, 11(1): e0005136. doi:10.1371/journal.pntd.0005136.

2. Fahal AH (2017) Mycetoma: A global medical and socio-economic dilemma. PLoS Negl Trop Dis 11(4): e0005509. https://doi.org/10.1371/ journal.pntd.0005509.
   
3. FlavioQuerioz-Telles, Ahmed Hassan Fahal, Diego R. Falci, Diego H. Caceres, Tom Chiller, Alessandro C. Pasqualotto. Neglected Endemic Mycoses, Accepted Lancet infectious diseases.

Publications 2016

4. EE Zijlstra, WWJ van de Sande, AH Fahal. Mycetoma, Mycetoma: A Long Journey from Neglect. Editorial, PLoS NTD, DOI:10.1371/journal.pntd.0004244 January 21, 2016.

5. Zijlstra EE, van de Sande WW, Welsh O, Mahgoub ES, Goodfellow M, Fahal AH. Mycetoma. Lancet Infect Dis. 16. 1, 100–112, January 2016. DOI: http://dx.doi.org/10.1016/S1473-3099(15)00359-X.

6. Scolding PS, Abbas MAQ, Omer RF, Fahal AH. Madurella mycetomatis-Induced Massive Shoulder Joint Destruction: A Management Challenge. PLoS Negl Trop Dis 2016; 10(8): e0004849. doi:10.1371/journal.pntd.0004849.

7. Omer RF, Seif EL Din N, Abdel Rahim FA, Fahal AH. Hand Mycetoma: The Mycetoma Research Centre Experience and Literature Review. PLoS Negl Trop Dis 2016;10(8): e0004886. doi:10.1371/journal.pntd.0004886.

8. Mohamed ElSW, Seif El Din N, Fahal AH. Multiple Mycetoma Lung Secondaries from Knee Eumycetoma: An Unusual Complication. PLoS Negl Trop Dis. 2016 Jul 21; 10(7):e0004735. doi: 10.1371/journal.pntd.0004735. eCollection 2016.

9. Fahal AH, Finkelman MA, Zhang Y, Van de Sande WW. Detection of (1→3)-β-D-glucan in eumycetoma patients. J ClinMicrobiol. 2016 Jul 20. pii: JCM.01478-16.

10. Nasr A, Abushouk A, Hamza A, Siddig E, Fahal AH. Th-1, Th-2 Cytokines Profile among Madurella mycetomatis Eumycetoma Patients. PLoS Negl Trop Dis. 2016 Jul 19; 10(7):e0004862. doi: 10.1371/journal.pntd.0004862. eCollection 2016.

11. Suleiman SH, Wadaella el S, Fahal AH. The Surgical Treatment of Mycetoma. PLoS Negl Trop Dis. 2016 Jun 23; 10(6):e0004690. doi: 10.1371/journal.pntd.0004690. eCollection 2016.

12. Smit S, Derks MF, Bervoets S, Fahal A, van Leeuwen W, van Belkum A, van de Sande WW. Genome Sequence of Madurella mycetomatis mm55, Isolated from a Human Mycetoma Case in Sudan. Genome Announc. 2016 May 26;4(3). pii: e00418-16. doi: 10.1128/genomeA.00418-16.

13. ELbadawi HS, Mahgoub E, Mahmoud N, Fahal AH. Use of immunoblotting in testing Madurella mycetomatis specific antigen. Trans R Soc Trop Med Hyg. 2016 May;110(5):312-6. doi: 10.1093/trstmh/trw023.


14. Wadal A, Elhassan TA, Zein HA, Abdel-Rahman ME, Fahal AH.  Predictors of Post-operative Mycetoma Recurrence Using Machine-Learning Algorithms: The Mycetoma Research Center Experience. PLoS Negl Trop Dis. 2016; 10(10): e0005007. doi:10.1371/journal.pntd.0005007

15. Mohamed NA, Fahal AH. Mycetoma Pulmonary Secondaries from a GlutealEumycetoma: An Unusual Presentation. PLoS Negl. Trop Dis. 2016; 10(10): e0004945. doi:10.1371/journal.pntd.0004945.

2015 publications

16. Ahmed SA, de HoogGS, Stevens DA, Fahal AH and van de Sande WJ. "In Vitro Antifungal Susceptibility of Coelomycete Agents of Black Grain Eumycetoma to Eight Antifungals Med Mycol. 2015 Jan 28. pii: myu098. [Epub ahead of print].

17. Hay RJ, Fahal AH. Mycetoma: an old and still neglected tropical disease. Trans R Soc Trop Med Hyg. 2015; 109(3):169-70. doi:10.1093/trstmh/trv003.

18. Ahmed SA, van de Sande WW, Stevens DA, Fahal A, van Diepeningen AD, Menken SB, de HoogGS. Revision of agents of black-grain eumycetoma in the order Pleosporales. Persoonia. 2014 Dec; 33:141-54. doi: 10.3767/003158514X684744. Epub 2014 Sep 16.

19. Nenoff P, van de Sande WW, Fahal AH, Reinel D, Schöfer H. Eumycetoma and actinomycetoma - an update on causative agents, epidemiology, pathogenesis, diagnostics and therapy. J EurAcadDermatolVenereol. 2015 Feb 27. doi: 10.1111/jdv.13008.]

20. Ahmed SA, de HoogGS, Stevens DA, Fahal AH, van de Sande WW. In vitro antifungal susceptibility of coelomycete agents of black grain eumycetoma to eight antifungals. Med Mycol. 2015; 53(3):295-301. doi: 10.1093/mmy/myu098. Epub 2015 Jan 28.

21. Ahmed SA, Kloezen W, Fahal AH, de HoogGS, van de Sande WW. In Vitro Interaction of Currently Used Azoles with Terbinafine against Madurella mycetomatis. Antimicrob Agents Chemother. 2015 Feb; 59(2):1373-4. doi: 10.1128/AAC.04487-14.

22. Fahal A, Mahgoub ES, EL Hassan AM, Jacoub AO, Hassan D. Head and Neck Mycetoma: The Mycetoma Research Centre Experience. PLoS Negl Trop Dis (2015) 9(3): e0003587. doi:10.1371/journal.pntd.0003587

23. Elfadil H, Fahal A, Kloezen W, Ahmed EM, van de Sande W. The In Vitro Antifungal Activity of Sudanese Medicinal Plants against Madurella mycetomatis, the Eumycetoma Major Causative Agent. PLoS Negl Trop Dis (2015) 9(3): e0003488. doi:10.1371/journal.pntd.0003488

24. Fahal AH, EL Hassan AM, Mahgoub ES, Rahman ME, Mycetoma in the Sudan: The Mycetoma Research Centre Update.‎ PLoS Negl Trop Dis. 2015 Mar 27; 9(3):e0003679. doi: 10.1371/journal.pntd.0003679. eCollection 2015 Mar.

25. HalaTaha, Ahmed Fahal, Wendy W. J. van de Sande. Mycetoma: Epidemiology, Treatment Challenges and Progress. Mycetoma: epidemiology, treatment challenges and progress. Res Rep Trop Med. 2015:6 31–36.

26. Wendy WJ van de Sande, Marian ten Kate, Wim van Vianen, Ahmed Fahal, Irma Bakker-Woudenberg. Amphotericin B but not itraconazole is able to prevent grain formation in experimental M. mycetomatis mycetoma in mice. Br J Dermatol. 2015 Jul 6. doi: 10.1111/bjd.14025.

27. Kloezen W, van Helvert-van Poppel M, Fahal AH, van de Sande WWJ. A Madurella mycetomatis Grain Model in Galleria mellonella Larvae. PLoS Negl Trop Dis 2015; 9(7): e0003926. doi:10.1371/journal.pntd.0003926.

28. Eshraga A. Ezaldeen, Raif Mohamed Ahmed, EL SammaniWadella, Nadia EL Dawi, Ahmed Hassan Fahal. Actinomycetoma induced Cervical Spinal Cord Compression: A rare and serious complication. JMM Case Reports. 2015; DOI 10.1099/jmmcr.0.000074.

29. Ahmed SA, van de Sande WW, Desnos-Ollivier M, Fahal AH, Mhmoud NA, de HoogGS. Application of Isothermal Amplification Techniques for the Identification of Madurella mycetomatis, the Prevalent Agent of Human Mycetoma. J ClinMicrobiol. 2015 Aug 5. pii: JCM.01544-15.

30. VerwerPEB, Notenboom CC, Eadie K, Fahal AH, Verbrugh HA, van de Sande WWJ. A polymorphism in the chitotriosidase gene associated with risk of mycetoma due to Madurella mycetomatis - a retrospective study PLoS Negl Trop Dis. 2015 Sep 2;9(9):e0004061. doi: 10.1371/journal.pntd.0004061. eCollection 2015.

31. Najwa MA, Badr M Yousif, Ahmed Fahal, Wendy van de Sande. The nature of the M. mycetomatis mycetoma granuloma tissue pigments. Khartoum Med J. 2015; 8 (2): 1105 – 1110.

32. Ahmed Hassan Fahal. Aggressive actinomycetoma. Khartoum Med J. 2015; 8 (2): 1116.

33. Emmanuel E. Siddig, Aghapy E. Siddig, Ali Edreis, Ahmed Omer Almobarak, Ahmed H Fahal. The Utility of Fine Needle Aspiration for cytology for the Diagnosis of Breast lesions in low sources area. Khartoum Med J. 2015; 8(3):1153-1157.

34. Emmanuel Edward Siddig, Najwa A. Mhmoud, Ahmed Hassan Fahal. Identification of M. mycetomatis fungus in pleural fluid and sputum of a patient with aggressive gluteal eumycetoma with pulmonary spread. Khartoum Med J 2015; 8(3): 1164-1167.

35. Emmanuel E. Siddig, Badr EL Din M. Yousif, Ali M. Edris, Ahmed H. Fahal. The Touch Imprint Cytology: A simple method for the diagnosis of mycetoma causative agents. Khartoum Med J –in press


Send to publication

1. Ahmed Hassan Fahal, Mycetoma Chapter, Medical Mycology

2. Hago AW, Suleiman SH, Fahal AH, EL Hassan AM. Breast Osteoid Osteoma:   A Case Report and Literature Review

3. Lamyaa AM EL Hassan, WMElamin.  AA Abdelhameed, MAM Ayis, Ameera Adam, AH Fahal, AM Musa, AM EL Hassan. Zygomycosis: Case series of seven patients from a single centre in Sudan.

4. Amel Altayeb Ahmed, Wendy van de Sande, Ahmed Hassan Fahal. Mycetoma Laboratory Diagnosis: Review Article.

5. Kloezen W, Parel F, Brüggemann R, Asouit K, Helvert-van Poppel, M, Fahal A, Mouton J, van de Sande, Wendy WJ. Amphotericin B and terbinafine but not the azoles prolong survival in Galleria mellonella larvae infected with Madurella mycetomatis."

6. Wendy van de Sande, Ahmed Fahal, Julian Alberto Serrano, Alexandro Bonifaz, Ed Zijlstra. Closing the mycetoma knowledge gap.

7. Eiman Siddig Ahmed Saad, Ahmed Hassan Fahal. Broncho-pleuro-cutaneous fistula and pneumothorax: Rare challenging complications of chest wall eumycetoma.


 

                                                                                                                                                                                                                                     

Published Books

                                                                                                                                                                                    

Mycetoma Clinicopathological Monograph.


Prof. Ahmed Hassan Fahal,MBBS, FRCS, FRCSI, FRCSG MS, MD, FRCP(London)
Professor of Surgery, University of Khartoum

book

José Antonio Serrano
Ángel Horacio Sandoval
Blaine L. Beaman
Click to download pdf Actinomicetoma

libro1[1]

Dr.   WW van de de Sande
Department of Medical Microbiology and Infectious Diseases
Erasmus Medical Center
Rotterdam University

 

                                                                                                                                                                                       

Publications

                                                                                                                                                                                       

1.Fahal AH, Hassan MA. Mycetoma. Br J Surg. 1992; 79(11): 1138-1141. PMID: 1467883.

2.Fahal AH, Suliman SH, Gadir AFA, EL Hag IA, EL Amin FI, Gumaa SA, Mahgoub ES. Abdominal wall mycetoma: an unusual presentation. Trans R Soc Trop Med Hyg. 1994; 88(1):78-80. PMID: 8154012.

3.Fahal AH, Suliman SH. Clinical presentation of mycetoma. Sudan Med J. 1994; 32: 46-66.

4.Fahal AH, El Hassan AM, Abdelalla AO, Sheik HE, Cystic mycetoma: an unusual clinical presentation of Madurella mycetomatis. Trans R Soc Trop Med Hyg. 1998; 92:6-67.

5.Fahal AH, EL Toum EA, EL Hassan AM, Gumaa SA, Mahgoub ES. A preliminary study on the ultrastructure of Actinomadura pelletieri and its host tissue reaction.   J Med Vet Mycol. 1994; 32: 343-348. PMID: 7844700.

6.EL Hassan AM, Fahal AH, EL Hag IA, Khalil EAG. The pathology of mycetoma: Light microscopic and ultrastructural features. Sudan Med J. 1994; 32: 23-45.

7.Fahal AH, Hassan MA, Sanhouri M. Surgical treatment of mycetoma. Sudan Med J. 1994; 32: 98-104.

8.Fahal AH, EL Toum EA, EL Hassan AM, Gumaa SA, Mahgoub ES. Host tissue reaction to Madurella mycetomatis: New classification. J Med Vet Mycol. 1995; 33: 15-17.

9.EL Hag IA, Fahal AH, Khalil EAG. Fine needle aspiration cytology of mycetoma. Acta Cytologica. 1996; 40(3): 461-46.

10.Fahal AH, Omer SM, El Razig SA, Ali ABE, Mahdi EMA, Mahgoub ES. Thyroid function in mycetoma patients. East Afr Med J. 1995; 72(7): 454-456. PMID: 7498029.

11.Fahal AH, Azziz KAA, Suliman SH, Galib HV, Mahgoub ES. Dual infection with mycetoma and tuberculosis. East Afr Med J. 1995; 72(11): 749-750. PMID: 8904072.

12.Mohamed ARO, Fahal AH, Venge V. Immunoglobulin and inflammatory markers profile in mycetoma. East Afr Med J. 1996; 73(4): 212 (Letter). PMID: 8698027.

13.Fahal AH, Yagi HI, EL Hassan AM. Mycetoma induced palatal deficiency and pharyngeal plexus dysfunction. Trans R Soc Trop Med Hyg. 1996; 90: 676-677. PMID: 9015514

14.Fahal AH, Sheikh HE, EL Hassan AM. Pathological fracture in mycetoma. Trans R Soc Trop Med Hyg. 1996; 90: 675-676. PMID: 9015513.

15.Fahal AH, Sharfi AR, Sheikh HE, EL Hassan AM. Mycetoma: Uncommon complication. Trans R Soc Trop Med Hyg. 1996; 89: 550-552.

16.Fahal AH, Sadig ME, Suliman SH, EL Razig SA, Mahgoub ES. Lack of association between ABO blood groups and Rh factor and the tendency to develop mycetoma. East Afr Med J. 1996; 11: 769. (Letter). PMID: 8997873

17.Fahal AH, EL Hag IA, Gadir AFA, EL Lider AR, Baraka OZ, EL Hassan AM. The blood supply and vasculature in mycetoma. J Med Vet Mycol. 1997; 35: 101-106. PMID: 9147269

18.Fahal AH, Sheikh HE, EL Lider MA, Homeida MA, EL Arabi YE, Mahgoub ES. Ultrasonic imaging in mycetoma. Br J Surg. 1997; 78: 765-766. PMID: 9278658

19.Ahmed AOA, Fahal AH, Abugroun EAM, Zijlstra E, Belkum A van, Verbrugh HA. Unexpected high prevelance of secondary bacterial infection in mycetoma. J Clin Microbiol. 1998; 36(3): 850-851. PMID: 9817883. [Download free Article].

20.Fahal AH, Sharfy ARA. Vulval mycetoma: a rare cause of bladder outlet obstruction. Trans R Soc Trop Med Hyg. 1998; 92: 652-653. PMID: 10326112.

21.Ahmed AO, Mukhtar MM, Kools-Sijmons M, Fahal AH, de Hoog S, van den Ende BG, Zijstara, ED, Verburgh H, Abugroun ESA, EL Hassan AM, van Beklkum A. Development of a species-specific PCR RFLP procedure for the identification of Madurella mycetomatis. J Clin Microbiol. 1999; 37(10):3175-8. PMID: 10488173. [Download Free Article]

22.Fahal AH. The management of mycetoma. Post-Grad -Caribbean. 2000;16(4):229-232.

23.EL Hassan AM, Fahal AH, Ahmed AO, Ismail A, Veress B. The immunopathology of actinomycetoma lesions caused by Streptomyces somaliensis. Trans R Soc Trop Med Hyg. 2001: 95(1); 89-92. PMID: 11280076

24.Ahmed AOA, Adelmann D, Fahal AH, Verbrugh HA, Van Belkum A, De Hoog S. Environmental occurrence of Madurella mycetomatis, major agent of human eumycetoma in Sudan. J Clin Microbiol. 2002 40(3): 1031-1036. PMID: 11880433. [Download Free Article]

25.Ahmed AOA, van Vianen W, ten Kate M, van de Sande WWJ, Van Belkum A, Fahal AH, Verbrugh HA, Bakker- Woudenberg IAJM. A murine model of Madurella mycetomatis eumycetoma. FEMS Immunol Med Microbiol. 2003; 37: 29-36. PMID: 12770757. [Download Free Article].

26.Ahmed AOA, van de Sande W, Van Belkum A, Verbrugh HA, Fahal A H, van Belkum A. Madurella mycetomatis strains from mycetoma lesions in Sudanese patients are clonal. J Clin Microbiol. 2003; 41(10):4537-41 PMID: 14532179. [Download free article]

27.Abd Bagi ME, Fahal AH, Sheik HE, Abdul Wahab O, Taifoor MK, Osmanr EM. High incidence of pathological fracture in mycetoma. Trans R Soc Trop Med Hyg. 2003; 97(5):582-4. PMID: 15307432

28.Fahal AH. Mycetoma thorn on the flesh Review article. Trans R Soc Trop Med Hyg. 2004; 98(1):3-11. Review.

29.Ahmed AO, van de Sande WW, van Vianen W, van Belkum A, Fahal AH, Verbrugh HA, Bakker-Woudenberg IA.In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay. Antimicrob Agents Chemother. 2004; 48(7):2742-6. PMID: 15215141. [Download Free Article].

30.Ahmed AO, van Leeuwen W, Fahal A, van de Sande W, Verbrugh H, van Belkum A. Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect Dis. 2004; 4(9):566-74. Review. PMID: 15336224

31.EL Hassan AM, Fahal AH, Veress B. Cell phenotypes, immunoglobulins, and complement in lesion of eumycetoma caused by Madurella mycetomatis. Sud J Dermato 2006; 4 (1):2-5.

32.van de Sande WW, Fahal A, Verbrugh H, van Belkum A. Polymorphisms in genes involved in innate immunity predispose toward mycetoma susceptibility. J Immunol. 2007; 179(5):3065-74. PMID: 17709521. [Download Free Article].

33.van de Sande WW, de Kat J, Coppens J, Ahmed AO, Fahal A, Verbrugh H, van Belkum A. Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole. Microbes Infect. 2007; 9: 1114-1123. PMID: 17644456.

34.van de Sande WW, Fahal A, Verbrugh H, van Belkum A. Madurella mycetomatis compounds cross-reactive with galactomannan are detectable in culture supernatant but not in serum. J Med Microbiol. 2007; 56: 869-70. PMID: 17510278. [Download Free Article].

35.Ahmed AA, van de Sande WW, Fahal A, Bakker-Woudenberg I, Verbrugh H, van Belkum A. Management of mycetoma: major challenge in tropical mycoses with limited international recognition. Curr Opin Infect Dis. 2007; 20(2):146-51. PMID: 17496572.

36.van de Sande WW, Fahal AH, Riley TV, Verbrugh H, van Belkum A. In vitro susceptibility of Madurella mycetomatis, prime agent of Madura foot, to tea tree oil and artemisinin. J Antimicrob Chemother. 2007; 59(3):553-5 PMID: 17324961. [Download Free Article].

37.Hussein A, Ahmed AEM, Fahal AH, Mahmoud A, Sidig A. Awad K, Ahmed EM. Cervical cord compression secondary to mycetoma infection. Sud J Pub Health. 2007; 2(2): 112-115.

38.Quintana ET, Wierzbicka K, Mackiewicz P, Osman A, Fahal AH, Hamid ME, Zakrzewska-Czerwinska J, Maldonado LA, Goodfellow M. Streptomyces sudanensis sp. nov., a new pathogen isolated from patients with actinomycetoma. Antonie Van Leeuwenhoek. 2008; 93(3):305-13. PMID: 18157699.

39.Dejan Stojković, Marina Soković, Ana Džamić, Mihailo Ristić, Ahmed Fahal Silvana Petrović, Ivana Djujić Sami Khalid. In vitro Susceptibility of Actinomadura madurae Clinical Isolates to Turpentine Oil of Pinus pinaster and α-Pinene. Arch. Biol. Sci., Belgrade. 2008; 60 (4): 697-701.

40.Abd El-Bagi MEB, Fahal AH. Mycetoma revisited. Incidence of various radiographic signs. Saudi Med J. 2009;30(4):529-33. PMID: 19370281.

41.Yousif BM, Fahal AH, Yahia MY. The Cell Block Technique: A New Diagnostic Tool for Mycetoma. Trans R Soc Trop Med Hyg. 2010; 104(1):6-9.

42.Fahal AH, Abu Sabaa. AH. Mycetoma in Children. Trans R Soc Trop Med Hyg. 2010; 104: 117–12. PMID: 19716573.

43.Fahal, AH. Management of mycetoma. Expert Rev Dermatol. 2010; 5(1), 87–93.

44.van de Sande WWJ, Fahal AH, Tavakol M, van Belkum A, Polymorphisms in catechol-O-methyltransferase and cytochrome p450 subfamily 19 genes predispose towards Madurella mycetomatis-induced mycetoma susceptibility. Med Mycol. 26.2.2010; 48(7):959-68. PMID: 20184498

45.van de Sande WW, Fahal AH, Bakker-Woudenberg IA, van Belkum A. Madurella Mycetomatis is not susceptible to the Echinocandin class of antifungal agents. Antimicrob Agents Chemother. 2010 june, 54(6):2738-2740. PMID: 20350944

46.Fahal AH, Rahman I A, El-Hassan AM, EL Rahman ME, Zijlstra EE. The efficacy of itraconazole in the treatment of patients with eumycetoma due to Madurella mycetomatis. Trans R Soc Trop Med Hyg. 2011; 105(3):127-32.

47.Alex van Belkum, Ahmed H. Fahal, Wendy W.J va n de Sande. In Vitro Susceptibility of Madurella Mycetomatis to Posaconazole and Terbinafine. Antimicrob Agents Chemother. 2011; 55(4):1771-3.

48.Fahal AH, EL Sheik H, El Hassan AM. Venous Varicosity in Mycetoma. Sudan Med J. 2011; 47(1): 20-24.

49.Fahal AH. Mycetoma. Review article, Khartoum Med J. 2011; 4(1): 514-523.

50.de Klerk N, de Vogel C, Fahal AH, van belkum A, van de Sande W. fructose-bisphosphate aldolase and pyruvate kinase, two novel immunogens in madurella mycetomatis. Med Mycol. 2012; 50(2):143-51.

51.Paul A Hoskisson, Ralph Kirby, Vartul Sangal, Nicholas P Tucker, Jolanta Zakrzewska-Czerwinska, Katarzyna Wierzbicka, Paul R Herron, Chun-Jong Chu, Dr. govind chandra, Ahmed Fahal, Michael Goodfellow. The draft genome sequence of the human pathogen Streptomyces somaliensis, a significant cause of actinomycetoma. J Bacteriol. 2012; 194(13):3544-5.

52.Zein HAM, Fahal AH, Mahgoub, ES, EL Hassan T, Abdel Rahman, ME, The Predictors of Cure, Amputation & Follow-up dropout among Mycetoma Patients as seen at The Mycetoma Research Centre, University of Khartoum. Trans R Soc Trop Med Hyg. 2012; 106(11):639-44.

53.Mhmoud NA, Ahmed SA, Fahal AH, de Hoog GS, Gerrits van den Ende AH, van de Sande WW. Pleurostomophora ochracea, a novel agent of human eumycetoma with yellow grains.J Clin Microbiol. 2012; 50(9):2987-94

54.Mhmoud NA, Fahal AH, van de Sande WW. CD4+ T-lymphocytopenia in HIV-negative tuberculosis patients in Sudan. J Infect. 2012; 65(4):370-2.

55.de Hoog GS, van Diepeningen AD, Mahgoub el-S, van de Sande WW. New species of Madurella, causative agents of black-grain mycetoma. J Clin Microbiol. 2012; 50(3):988-94.

56.Fahal AH, Arbab MAR, EL Hassan AM. Aggressive Clinical Presentation of Mycetoma due to Actinomadura Pelletierii. Khartoum Med J. 2012; 5(1): 699-702.

57.Mohamed, EW, Suleiman HS, Fadella, AI, Fahal, AH. Aggressive Perineal and Pelvic Eumycetoma: An unusual and challenging problem to treat. Khartoum Med J. 2012; (5)2:771-774.

58.Wendy Kloezen, Jacques F. Meis, Ilse Curfs-Breuker, Ahmed Fahal, Wendy W. J. van de Sande. In vitro antifungal activity of isavuconazole to Madurella mycetomatis. Antimicrob Agents Chemother. 2012; 56(11):6054-6.

59.Mohamed EW, Mohamed, ENA, Yousif, BM, Fahal, AH. Tongue Actinomycetoma due to Actinomadura madurae: A rare clinical presentation. J Oral Maxillofac Surg. 2012; 70(11):e622-4.  

60.EL Shamy, ME, Fahal AH, Shakir MY, Homedia MMA. New MRI Grading System for the Diagnosis and Management of Mycetoma. Trans R Soc Trop Med Hyg. 2012; 106(12):738-42.

61.Fahal AH, van de Sandy, WW. The Epidemiology of mycetoma. Current Fungal Infection Reports. 2012; 6( 4): 320-326

62.Mhmoud NA, Fahal AH, van de Sande WW. The association between the interleukin-10 cytokine and CC chemokine ligand 5 polymorphisms and mycetoma granuloma formation. Med Mycol. 2012 Dec 4. [Epub ahead of print

63.Fahal, AH, The Mycetoma Research Centre, University of Khartoum, Sudan: a success story that need support. IJSR. 2013 3(1): 1-13.

64.Ibrahim AI, El Hassan AM, Fahal A, van de Sande WW. A histopathological exploration of the Madurella mycetomatis grain.PLoS One. 2013; 8(3):e57774. doi: 10.1371/journal.pone.0057774. Epub 2013 Mar 6.

65.Suleiman AM, Fahal AH. Oral cavity eumycetoma: a rare and unusual condition. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013; 115(4): e23-5.

66.Ehab AM Elagab, Maowia M Mukhtar, Ahmed H Fahal, Wendy WJ van de Sande. Peripheral Blood Mononuclear Cells of Mycetoma Patients React Differently to Madurella mycetomatis Antigens than Healthy Endemic Controls. PLoS Negl Trop Dis. 2013; 7(4): e2081. doi: 10.1371/journal.pntd.0002081. Print 2013 Apr.

67.van Hellemond JJ, Vonk AG, de Vogel C, Koelewijn R, Vaessen N, Fahal AH, van Belkum A, van de Sande WW. Association of eumycetoma and schistosomiasis. PLoS Negl Trop Dis. 2013 May 23;7(5):e2241. doi: 10.1371/journal.pntd.0002241. Print 2013 May

68.van Belkum A, Fahal A, van de Sande WW Mycetoma caused by Madurella mycetomatis: a completely neglected medico-social dilemma. Adv Exp Med Biol. 2013; 764:179-89.

69.Fahal AH, Elkhawad AO. Managing mycetoma: guidelines for best practice Expert ‎Rev Dermatol 2013; 8(3)‎: 301-307.

70.GS de Hoog, S. Abdalla Ahmed, MJ Najafzadeh, DA Sutton, M. Saradeghi Keisari, AH Fahal, U. Eberhart, B. Stielow, GJ Verkley, Lian Xin, WWJ van de Sande. Phylogenetic findings suggest possible new habitat and routes of infection of human eumycetoma. PLoS Negl Trop Dis. 2013 May 16; 7(5):e2229. doi: 10.1371/journal.pntd.0002229. Print 2013 May

71.Najwa A. Mhmoud, Ahmed H. Fahal, Wendy W. J. Van De Sande. The association between the interleukin-10 cytokine and CC chemokine ligand 5 polymorphismsand mycetoma granuloma formation. Med Mycol 2013, 51, 527–533.

72.Mhmoud N, Fahal A, Wendy van de Sande WJ. Polymorphisms of interleukin-10 and CCL5 Genes in Tuberculosis. Trop Med Int Health. 2013; 18(9): 1119-1127. doi:10.1111/tmi.12141

73.Ezaldeen EA, Fahal AH, Osman A. Mycetoma herbal treatment: the Mycetoma Research Centre, Sudan experience. PLoS Negl Trop Dis. 2013 Aug 22;7(8):e2400. doi: 10.1371/journal.pntd.0002400. e Collection 2013.

74.Fahal AH, Shaheen S‎. Jones DH. Orthopaedic Aspects of Mycetoma: Instructional Review. Bone Joint J 2014; 96-B: 420–5. doi: 10.1302/0301-620X.96B3.31421.

75.Al Dawi AF, Mustafa MI, Fahal AH, EL Hassan AM, Bakhiet SM, Mahgoub ES, Mergani A, Mukhtar MM. The Association of HLA-DRB1 & HLA-DQB1 and the occurrence of Eumycetoma. Khartoum Med J – 2013; 6(3): 923 - 929

76.Geneugelij K, Kloezen W, Fahal AH, van de Sande WWJ. Active matrix metalloprotease-9 is associated with the collagen capsule surrounding the M. mycetomatis grain in mycetoma. PLoS Negl Trop Dis Published: March 27, 2014 DOI: 10.1371/journal.pntd.0002754.

77.Wendy W. J. van de Sande, El Sheikh Maghoub, Ahmed H. Fahal, Michael Goodfellow, Oliverio Welsh, Ed Zijlstra. The Mycetoma Knowledge Gap: Identification of Research Priorities. PLoS Negl Trop Dis Published: March 27, 2014 DOI: 10.1371/journal.pntd.0002667.

78.Fahal AH, Mahgoub ES, EL Hassan ESM, EL Tayeb E, EL Hassan AM. Eye Eumycetoma: The Mycetoma Research Centre, Sudan Case Series & Literature Review. Infectious Diseases in Clinical Practice 6 June 2014, doi: 10.1097/IPC.0000000000000157.

79.Sarah Abdalla Ahmed, Wendy Kloezen, Frederick Duncanson, Ed Zijlstra, G. Sybren de Hoog, Ahmed H. Fahal, Wendy WJ van de Sande. Madurella mycetomatis is highly susceptible towards Ravuconazole. PLoS Negl Trop Dis June 19, 2014 DOI: 10.1371/journal.pntd.0002942

80.Najwa A Mhmoud, Ahmed H Fahal, El Sheikh Mahgoub, Wendy W J van de ‎Sande. The combination of Amoxicillin-clavulanic acid and ketoconazole proved to be ‎effective and safe for treatment of Madurella mycetomatis eumycetoma patients ‎with secondary Staphylococcus aureus infection. PLoS Negl Trop Dis June 19, 2014 DOI: 10.1371/journal.pntd.0002959.

81.Wendy W. J. van de Sande, Ahmed H. Fahal, Michael Goodfellow, El Sheikh Maghoub, Oliverio Welsh, Ed Zijlstra. The merits and pitfalls of the currently used diagnostic tools in mycetoma. PLoS Negl Trop Dis July 03, 2014 DOI: 10.1371/journal.pntd.0002918

82.Ahmed SA, van de Sande WJ, Stevens DA , Fahal AH, van Diepeningen A, Menken SBJ, and de Hoog GS. Revision of agents of black-grain eumycetoma in the order Pleosporales. Persoonia 2014; 33: 141–154.

83.Samy AM, van de Sande WWJ, Fahal AH, Peterson AT Mapping the Potential Risk of Mycetoma Infection in Sudan and South Sudan Using Ecological Niche Modeling. PLoS Negl Trop Dis 2014; 8(10): e3250. doi:10.1371/journal.pntd.0003250

84.Welsh O, Al-Abdely HM, Salinas-Carmona MC, Fahal AH (2014) Mycetoma Medical Therapy. PLoS Negl Trop Dis 8(10): e3218. doi:10.1371/journal.pntd.0003218. http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0003218

85.Fahal A, Mahgoub ES, EL Hassan AM, Abdel-Rahman ME, Alshambaty Y, Ed E Zijlstra A New Model for Management of Mycetoma in the Sudan. PLoS Negl Trop Dis 2014, 8(10): e3271. doi:10.1371/journal.pntd.0003271

86.Fahal AH. Mycetoma Comm Dermato J. 2014; 10: 15-17.

87.Sarah A. Ahmed, Bert Gerrits van den Ende, Ahmed H. Fahal, Wendy W. J. van de Sande, GS. de Hoog. Rapid Identification of Black Grain Eumycetoma causative agents Using Rolling Circle Amplification. PLoS Negl Trop Dis. 2014 Dec 4;8(12):e3368. doi: 10.1371/journal.pntd.0003368. eCollection 2014 Dec.

88.Kimberly Eadie, Ahmed Fahal, Wendy WJ van de Sande. In vitro activity of antiseptic solutions against M. mycetomatis, implications on eumycetoma management. Br J Dermatol. 2014 Nov 27. doi: 10.1111/bjd.13570. [Epub ahead of print]

89.Ahmed AK Ahmed, SH Suleiman, Fahal AH Aggressive Uncontrolled Gluteal Eumycetoma Invading the Pelvic Cavity and ‎the Spinal Cord: Unusual Clinical Presentation. Khartoum Med J. 2014; 7(2): 1005 – 1007.

90.Ahmed SA, Kloezen W, Fahal AH, de Hoog GS, van de Sande WW. In Vitro Interaction of Currently Used Azoles with Terbinafine Against Madurella mycetomatis. Antimicrob Agents Chemother. 2014 Dec 8. pii: AAC.04487-14. [Epub ahead of print]


Contribution to Books, Guidelines & News Letters

91.van de Sande WWJ, Fahal AH, de Hoog GS, Van Belkum A Madurella. In: Liu D, editor. Molecular detection of human fungal pathogens. Boca Raton: CRC Press, Taylor & Francis Group. 2011, pp. 117–128.

92.Fahal, AH Mycetoma in Richard, Guerrant, Walker, Peter, Tropical Infectious Diseases: Principles, Pathogens and Practice. Third edition, Elsevier Publisher, 2011, chapter 83, pp. 565-568

93.Fahal AH. Mycetoma in Williams, Bulstrode, O'Connell, Bailey and Love's Short Practice of Surgery 26E: 26th Edition, Oxford University Press, 2013, pp 64-68.

94.van Belkum A, Fahal, AH, van de Sande WW. Mycetoma by madurella mycetomatis: A completely neglected medico-social dilemma. In Hot Topics in Infection and Immunity in Children IX. Springer Science & Business Media New York 2012

95.Fahal AH, Mycetoma: Clinico-pathological Monograph, University of Khartoum Press. 2006.

96.Fahal AH, Actinomycetoma in Africa: in Serrano JA, Sandoval AH, Beaman BL. Actinomicetoma, Merida, Venezuela, 2006.

97.Hassan MA, Fahal AH. Mycetoma: in Tropical Surgery, Kamil R, Lumbly J, Westminster Publication LTD, 2004.

98.Fahal AH, Evidence Based Guidelines for the Management of Mycetoma Patients, 2001.

 

 


Electronic Publications

·     Virtual Patients Campus

Mycetoma virtual patients campus at the University of Khartoum website

   Other Publications on Mycetoma from the Sudan

 

Publications 2016